Insider Selling: HealthEquity, Inc. (HQY) VP Sells 9,500 Shares of Stock
HealthEquity, Inc. (NASDAQ:HQY) VP Darcy G. Mott sold 9,500 shares of HealthEquity stock in a transaction that occurred on Friday, October 20th. The stock was sold at an average price of $49.90, for a total value of $474,050.00. Following the completion of the sale, the vice president now directly owns 90,500 shares in the company, valued at approximately $4,515,950. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
HealthEquity, Inc. (NASDAQ HQY) traded down 3.72% during trading on Tuesday, hitting $49.19. The stock had a trading volume of 319,273 shares. HealthEquity, Inc. has a 12 month low of $30.34 and a 12 month high of $54.95. The company has a market cap of $2.98 billion, a PE ratio of 72.98 and a beta of 1.80. The company’s 50 day moving average is $48.63 and its 200-day moving average is $47.29.
HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.13. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The firm had revenue of $56.90 million for the quarter, compared to the consensus estimate of $55.66 million. During the same quarter last year, the business posted $0.16 earnings per share. The firm’s revenue was up 28.7% compared to the same quarter last year. On average, equities research analysts predict that HealthEquity, Inc. will post $0.71 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/10/24/insider-selling-healthequity-inc-hqy-vp-sells-9500-shares-of-stock.html.
Several research firms have recently weighed in on HQY. Cantor Fitzgerald boosted their target price on HealthEquity from $55.00 to $56.00 and gave the company an “overweight” rating in a research report on Wednesday, July 5th. Zacks Investment Research raised HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a research report on Wednesday, July 12th. BidaskClub downgraded HealthEquity from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. TheStreet raised HealthEquity from a “c” rating to a “b” rating in a research report on Monday, July 31st. Finally, Oppenheimer Holdings, Inc. reissued a “buy” rating and set a $61.00 target price on shares of HealthEquity in a research report on Wednesday, September 6th. One analyst has rated the stock with a sell rating, one has issued a hold rating and nine have assigned a buy rating to the company. HealthEquity has an average rating of “Buy” and an average target price of $57.17.
A number of institutional investors have recently made changes to their positions in HQY. BlackRock Inc. increased its stake in HealthEquity by 157,852.9% during the first quarter. BlackRock Inc. now owns 5,589,953 shares of the company’s stock worth $237,293,000 after acquiring an additional 5,586,414 shares during the last quarter. Janus Henderson Group PLC increased its stake in HealthEquity by 627.9% during the second quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock worth $105,292,000 after acquiring an additional 1,822,732 shares during the last quarter. FMR LLC increased its stake in HealthEquity by 45.6% during the second quarter. FMR LLC now owns 2,235,150 shares of the company’s stock worth $111,378,000 after acquiring an additional 699,728 shares during the last quarter. TimesSquare Capital Management LLC acquired a new stake in HealthEquity during the second quarter worth $25,822,000. Finally, Vanguard Group Inc. increased its stake in HealthEquity by 6.2% during the first quarter. Vanguard Group Inc. now owns 4,115,237 shares of the company’s stock worth $174,691,000 after acquiring an additional 240,136 shares during the last quarter. Hedge funds and other institutional investors own 90.95% of the company’s stock.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.